Abstract:Changes in the oxidant/antioxidant environment of aging Leydig cells have been shown to be correlated with the reduced ability of these cells to produce testosterone. We hypothesized that an altered redox environment might result in increased susceptibility to pro-oxidants, and that this might have an impact on steroidogenic function. To begin to test this hypothesis, we experimentally manipulated intracellular glutathione (GSH) concentration in MA-10 Leydig cells, and examined whether the susceptibility of the GSH-depleted cells to oxidative stress was affected. Incubation of MA-10 cells with buthionine sulfoximine (BSO, 100 µM, 18 h) or diethyl maleate (DEM, 200 µM, 30 min) reduced GSH content by more than 70%, while treatment of the cells with 3H-1,2-dithiole-3-thione (D3T, 200 µM, 24 hr) increased the GSH concentration to twice that of the control cells. Depletion of GSH significantly increased the susceptibility of the cells to oxidative stress induced by tert-butyl hydroperoxide (t-BuOOH). In contrast, increasing GSH greatly protected the cells from the same stressor. Thus, the ED50 of progesterone production was reduced from 400 µM t-BuOOH in the control cells to less than 50 µM in GSH-depleted cells. Increasing GSH with D3T greatly increased the ED50 from 400 µM to more than 800 µM. Cell viability, assayed by MTT reduction and ATP production, was significantly affected by t-BuOOH only at concentrations of 100 µM or higher whereas progesterone production was affected by t-BuOOH at much lower (12.5 µM) concentration. Intracellular ROS concentration, as measured by 2, 7-dichlorodihydrofluorescein diacetate (DCF) fluorescence, was significantly increased in GSH-depleted cells in response to t-BuOOH at 50-100 µM. The changes in progesterone and ROS production induced by GSH were prevented by restoration of the cellular GSH pool with glutathione ethyl ester (GSHEE), or by treating the cells with the antioxidant N-acetyl-cysteine (NAC). Two steps of the steroidogenic pathway were particularly sensitive to oxidative stress following GSH depletion: StAR protein synthesis and the conversion of cholesterol to pregnenolone by P450scc within the mitochondria. The results of these studies, taken together, are consistent with the hypothesis that alteration in the oxidant/antioxidant environment may play a significant role in the increased sensitivity of MA-10 cells to pro-oxidant stress, and thus perhaps to the age-related reduced ability of testicular Leydig cells to produce testosterone. Research supported by NIH Grants AG026721 (to H.C.) and AG21092 (to B.R.Z.) from the National Institute on Aging and NIH Training Grant ES07141 (to A.S.M.) from the National Institute of Environmental Health Sciences.

Stem Leydig Cells in the Adult Testis: Characterization, Regulation and Potential Applications

Androgen-Forming Stem Leydig Cells: Identification, Function and Therapeutic Potential

Generation of Leydig-like Cells: Approaches, Characterization, and Challenges

Directed Mouse Embryonic Stem Cells into Leydig-Like Cells Rescue Testosterone-Deficient Male Rats in Vivo.

Identification of Rat Testicular Leydig Precursor Cells by Single-Cell-RNA-Sequence Analysis

Differentiation of Adult Stem Cells Derived from Bone Marrow Stroma into Leydig or Adrenocortical Cells.

Transplanted Human P75-Positive Stem Leydig Cells Replace Disrupted Leydig Cells for Testosterone Production

Reconstructing the Stem Leydig Cell Niche via the Testicular Extracellular Matrix for the Treatment of Testicular Leydig Cell Dysfunction

[Progress on the Research of Stem Leydig Cell Line in the Testis of Rodents].

Characterization of Nestin-positive stem Leydig cells as a potential source for the treatment of testicular Leydig cell dysfunction

Effect of Glutathione Depletion on Susceptibility of Ma-10 Leydig Cell Steroidogenesis to Oxidative Stress

Transplantation of CD51+ Stem Leydig Cells: A New Strategy for the Treatment of Testosterone Deficiency

Leydig cell transplantation restores androgen production in surgically castrated prepubertal rats.

Differentiation of human induced pluripotent stem cells into Leydig-like cells with molecular compounds

Fetal Leydig cells: What we know and what we don't

High-fidelity Reprogramming into Leydig-like Cells by CRISPR Activation and Paracrine Factors.

Differentiation of bone marrow mesenchymal stem cells into Leydig-like cells with testicular extract liquid in vitro

A comprehensive atlas of testicular interstitium reveals Cd34+/Sox4+ mesenchymal cells as potential Leydig cell progenitors

Alterations of gene profiles in Leydig-cell-regenerating adult rat testis after ethane dimethane sulfonate-treatment.

Proliferated Leydig cells for engineered testis-like tissue regeneration with testosterone-secreting ability

Gonadotropins Facilitate Potential Differentiation of Human Bone Marrow Mesenchymal Stem Cells into Leydig Cells in Vitro.